+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antihistamine Drugs Market - Global Forecast 2025-2030- Product Image
Antihistamine Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Antihistamine Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6015086
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global antihistamine drugs market is undergoing pivotal transformation, shaped by regulatory developments, demographic shifts, and increasing emphasis on digital health integration. Forward-looking organizations recognize the strategic significance of adapting to evolving patient demands and regulatory frameworks to sustain growth and unlock new value opportunities.

Market Snapshot: Antihistamine Drugs Market Performance and Outlook

The Antihistamine Drugs Market grew from USD 279.74 million in 2024 to USD 294.71 million in 2025. It is expected to continue growing at a CAGR of 5.31%, reaching USD 381.59 million by 2030. Strong fundamentals in allergy management, robust R&D activity, and continual advances in delivery mechanisms underpin the sector’s momentum. Market participants face heightened scrutiny on safety and efficacy, with product innovation emerging as a key lever for differentiation and sustainable value creation.

Scope & Segmentation: Comprehensive Market Coverage and Framework

This report delivers a holistic analysis of the antihistamine drugs market, encompassing diverse dimensions and actionable insights for effective decision-making. The research covers multiple market segments, regions, and technologies:

  • Generation Types: First generation antihistamines and second generation antihistamines, each offering distinct clinical and commercial attributes.
  • Administration Routes: Dermal, nasal, ocular, oral, and parenteral, addressing varied clinical needs and patient convenience.
  • Distribution Channels: Hospital pharmacy (private and public), online pharmacy (proprietary platforms and third-party marketplaces), and retail pharmacy (chain and independent pharmacies).
  • Dosage Forms: Liquid (solutions, syrups), semi-solid (ointments), and solid (capsules, tablets) catering to patient and prescriber preferences.
  • Applications: Systemic (allergic rhinitis, urticaria) and topical (atopic dermatitis, conjunctivitis) indications.
  • Regional Coverage: Americas (including major U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, Southeast Asian economies).
  • Key Industry Players: Johnson & Johnson, GlaxoSmithKline plc, Bayer AG, Sanofi S.A., Novartis AG, Merck & Co., Inc., AstraZeneca plc, Teva Pharmaceutical Industries Ltd., Perrigo Company plc, Viatris Inc.

Key Takeaways: Strategic Insights for Decision-Makers

  • Regulatory tightening in major markets demands robust clinical development strategies and comprehensive post-marketing surveillance from drug manufacturers.
  • Adoption of digital health platforms and real-world data initiatives is redefining product differentiation and market access strategy across segments.
  • Personalized medicine concepts—guided by genomic biomarkers and advanced diagnostics—are facilitating targeted antihistamine therapies tailored to patient subpopulations.
  • Strategic collaboration with contract research organizations and regional players is accelerating time-to-market for next-generation formulations and supporting market expansion.
  • Technology-driven drug delivery advancements, including mucoadhesive sprays and transdermal patches, are enhancing patient adherence and product value proposition.
  • Regional nuances, such as reimbursement models in the Americas or price-sensitive settings in EMEA and APAC, require tailored go-to-market strategies to ensure optimal penetration and sustained value.

Tariff Impact: Implications of U.S. Tariff Adjustments

United States tariff changes implemented in 2025 have put upward pressure on active pharmaceutical ingredient sourcing costs and impacted international supply chains. Manufacturers and distributors have responded by reassessing their supplier bases, exploring nearshoring options, and adopting bulk procurement alliances to protect margins. Regional manufacturing partnerships and scenario-based financial planning have emerged as priority actions to safeguard supply continuity and cost competitiveness.

Methodology & Data Sources

The report’s foundation combines secondary research from regulatory filings, industry journals, and corporate disclosures with primary interviews of senior executives, key opinion leaders, and regulatory authorities. Proprietary surveys inform quantitative analysis on prescribing behavior and product access, while expert panel reviews strengthen analytical rigor and ensure reliable conclusions.

Why This Report Matters: Actionable Value for Industry Leaders

  • Enables executives to benchmark market entry and growth strategies using a multi-dimensional segmentation framework and region-specific insights.
  • Supports R&D planning with actionable guidance on emerging formulations, technology investments, and regulatory pathways.
  • Facilitates risk management and strategic planning for supply chains and pricing structures in a volatile regulatory landscape.

Conclusion

This report equips industry leaders with deep market intelligence, clarity on evolving dynamics, and strategic recommendations for the antihistamine drugs market. Leverage these insights to drive informed investments and achieve long-term competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in development of intranasal second-generation antihistamine delivery systems with enhanced absorption
5.2. Rising adoption of combination antihistamine and corticosteroid nasal sprays for chronic rhinosinusitis management
5.3. Growing investment in personalized antihistamine therapy guided by pharmacogenomic profiling for improved efficacy
5.4. Expansion of pediatric chewable antihistamine formulations to address safety and taste preferences in children
5.5. Integration of digital health platforms for remote allergy symptom tracking and antihistamine dose optimization
5.6. Competitive pricing pressure from generic second-generation antihistamines driving market consolidation and innovation
5.7. Accelerated R&D collaborations between biotech firms and pharma for novel H3 receptor modulators targeting allergic inflammation
5.8. Increasing consumer demand for plant-based hybrid antihistamine supplements promoting natural formulation strategies
5.9. Emergence of telemedicine-driven prescriptions boosting over the counter antihistamine usage for seasonal allergies
5.10. Regulatory approvals for sublingual antihistamine tablets enhancing patient compliance and dosing flexibility
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antihistamine Drugs Market, by Generation
8.1. Introduction
8.2. First Generation Antihistamines
8.3. Second Generation Antihistamines
9. Antihistamine Drugs Market, by Administration Route
9.1. Introduction
9.2. Dermal
9.3. Nasal
9.4. Ocular
9.5. Oral
9.6. Parenteral
10. Antihistamine Drugs Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacy
10.2.1. Private Hospital
10.2.2. Public Hospital
10.3. Online Pharmacy
10.3.1. Proprietary Platform
10.3.2. Third Party Marketplace
10.4. Retail Pharmacy
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Antihistamine Drugs Market, by Dosage Form
11.1. Introduction
11.2. Liquid
11.2.1. Solutions
11.2.2. Syrups
11.3. Semi Solid
11.3.1. Ointments
11.4. Solid
11.4.1. Capsules
11.4.2. Tablets
12. Antihistamine Drugs Market, by Application
12.1. Introduction
12.2. Systemic
12.2.1. Allergic Rhinitis
12.2.2. Urticaria
12.3. Topical
12.3.1. Atopic Dermatitis
12.3.2. Conjunctivitis
13. Americas Antihistamine Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Antihistamine Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Antihistamine Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. GlaxoSmithKline plc
16.3.3. Bayer AG
16.3.4. Sanofi S.A.
16.3.5. Novartis AG
16.3.6. Merck & Co., Inc.
16.3.7. AstraZeneca plc
16.3.8. Teva Pharmaceutical Industries Ltd.
16.3.9. Perrigo Company plc
16.3.10. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTIHISTAMINE DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTIHISTAMINE DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTIHISTAMINE DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTIHISTAMINE DRUGS MARKET: RESEARCHAI
FIGURE 26. ANTIHISTAMINE DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTIHISTAMINE DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. ANTIHISTAMINE DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIHISTAMINE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY FIRST GENERATION ANTIHISTAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SECOND GENERATION ANTIHISTAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PROPRIETARY PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY PROPRIETARY PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY THIRD PARTY MARKETPLACE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYRUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ALLERGIC RHINITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY URTICARIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CONJUNCTIVITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY CONJUNCTIVITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES ANTIHISTAMINE DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 151. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 152. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 153. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 154. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 155. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 162. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 163. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 164. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 165. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 166. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 167. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 168. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 169. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 170. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 171. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 174. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 175. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 176. CANADA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 178. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 179. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 184. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 185. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 186. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 187. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 190. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 191. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 192. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 193. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 194. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 195. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 196. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 197. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 200. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 201. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 202. MEXICO ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA ANTIHISTAMINE DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 309. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 310. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 311. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 312. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 313. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 316. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 317. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 318. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 319. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 322. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 323. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 324. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 325. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2018-2024 (USD MILLION)
TABLE 326. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY SEMI SOLID, 2025-2030 (USD MILLION)
TABLE 327. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 328. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 329. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2024 (USD MILLION)
TABLE 332. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY SYSTEMIC, 2025-2030 (USD MILLION)
TABLE 333. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 334. GERMANY ANTIHISTAMINE DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 335. FRANCE ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2018-2024 (USD MILLION)
TABLE 336. FRANCE ANTIHISTAMINE DRUGS MARKET SIZE, BY GENERATION, 2025-2030 (USD MILLION)
TABLE 337. FRANCE ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2018-2024 (USD MILLION)
TABLE 338. FRANCE ANTIHISTAMINE DRUGS MARKET SIZE, BY ADMINISTRATION ROUTE, 2025-2030 (USD MILLION)
TABLE 339. FRANCE ANTIHISTAMINE DRUGS MARKET SIZE, BY DIST

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antihistamine Drugs market report include:
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Bayer AG
  • Sanofi S.A.
  • Novartis AG
  • Merck & Co., Inc.
  • AstraZeneca plc
  • Teva Pharmaceutical Industries Ltd.
  • Perrigo Company plc
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 294.71 Million
Forecasted Market Value ( USD ) by 2030 $ 381.59 Million
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Allergy Drugs Market - Global Forecast 2025-2030 - Product Image

Allergy Drugs Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Antihistamine Nose Spray Market - Global Forecast 2025-2030 - Product Image

Antihistamine Nose Spray Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Antihistamine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Antihistamine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Antihistamine - Global Strategic Business Report - Product Image

Antihistamine - Global Strategic Business Report

  • Report
  • 479 Pages
  • Global
From
Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine, Immunotherapies), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Peanut Allergy Treatment Market Size, Share & Trends Analysis Report By Drug Class (Antihistamines, Epinephrine, Immunotherapies), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.